1331
        
        
          
            P90
          
        
        
          ñú×ĂÜăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          î-1,-2 Ēúąǰ-3 êŠ
        
        
          ĂÖćøÿøš
        
        
          ćÜđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          Ö
        
        
          Effects of Human Beta-Defensin-1, -2 and -3 on Osteoclastogenesis
        
        
          íîõĆ
        
        
          ìøǰýøĊ
        
        
          ēóîìĂÜ
        
        
          1*
        
        
          ǰóĆ
        
        
          ìîĉ
        
        
          îìøŤ
        
        
          ǰöîêøĊ
        
        
          ×Ýø
        
        
          2
        
        
          ǰÿćÙøøĆ
        
        
          êîŤ
        
        
          ǰÙÜ×č
        
        
          îđìĊ
        
        
          ֔
        
        
          3
        
        
          ǰß÷ćøóǰÿč
        
        
          óøøèßćêĉ
        
        
          4
        
        
          Ēúąÿč
        
        
          ìíĉ
        
        
          ßĆ
        
        
          ÷ǰÖùþèąðøąÖøÖĉ
        
        
          Ý
        
        
          5
        
        
          Thanapat Sripontong
        
        
          1
        
        
          *
        
        
          , PattaninǰMontreekachon
        
        
          2
        
        
          , Sakornrat Khongkhunthian
        
        
          3
        
        
          , Chayarop Supanchart
        
        
          4
        
        
          ,
        
        
          and Suttichai Krisanaprakornkit
        
        
          5
        
        
          ïìÙĆ
        
        
          é÷Š
        
        
          Ă
        
        
          Öćøýċ
        
        
          ÖþćîĊĚ
        
        
          đðŨ
        
        
          îÖćøýċ
        
        
          ÖþćĔîĀš
        
        
          ĂÜðäĉ
        
        
          ïĆ
        
        
          êĉ
        
        
          Öćøëċ
        
        
          Üñú×ĂÜăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          î-1, -2 Ēúąǰ-3 êŠ
        
        
          ĂÖćøÿøš
        
        
          ćÜđàúúŤ
        
        
          ÿúć÷
        
        
          ÖøąéĎ
        
        
          Öǰēé÷đÖĘ
        
        
          ïđúČ
        
        
          ĂéÝćÖĂćÿćÿöĆ
        
        
          ÙøĒúš
        
        
          üðŦ
        
        
          ũ
        
        
          îĒ÷ÖđàúúŤ
        
        
          đöĘ
        
        
          éđúČ
        
        
          Ăé×ćüßîĉ
        
        
          éēöēîîĉ
        
        
          üđÙúĊ
        
        
          ÷øŤ
        
        
          đàúúŤ
        
        
          ĒúąÖøąêčš
        
        
          îĔĀš
        
        
          Öúć÷đðŨ
        
        
          îđàúúŤ
        
        
          ÿúć÷
        
        
          ÖøąéĎ
        
        
          ÖǰìéÿĂïÙüćöđðŨ
        
        
          îóĉ
        
        
          þ×ĂÜăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          î-1, -2 Ēúąǰ-3 êŠ
        
        
          ĂđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          Öéš
        
        
          ü÷ǰMTT assayǰđúČ
        
        
          ĂÖÙüćöđך
        
        
          öך
        
        
          î
        
        
          øąéĆ
        
        
          ïìĊę
        
        
          ĕöŠ
        
        
          đðŨ
        
        
          îóĉ
        
        
          þêŠ
        
        
          ĂđàúúŤ
        
        
          đóČę
        
        
          ĂîĞ
        
        
          ćöćìéÿĂïñú×ĂÜăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          îìĆĚ
        
        
          Ü 3 ßîĉ
        
        
          éêŠ
        
        
          ĂÖćøÿøš
        
        
          ćÜđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          Öǰñú×ĂÜ
        
        
          Öćøýċ
        
        
          ÖþćóïüŠ
        
        
          ćǰăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          î-1 öĊ
        
        
          ñúĔîÖćøÖøąêčš
        
        
          îÖćøÿøš
        
        
          ćÜĒúąÖćøìĞ
        
        
          ćÜćî×ĂÜđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          ÖǰĔîìćÜêøÜך
        
        
          ćöǰăĉ
        
        
          ü
        
        
          ĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          î-3 öĊ
        
        
          ñúĔîÖćø÷Ć
        
        
          ï÷ĆĚ
        
        
          ÜÖćøÿøš
        
        
          ćÜĒúąÖćøìĞ
        
        
          ćÜćî×ĂÜđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          ÖǰÿŠ
        
        
          üîăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          î-2 ĕöŠ
        
        
          öĊ
        
        
          ñúêŠ
        
        
          Ă
        
        
          Öćøÿøš
        
        
          ćÜĒúąÖćøìĞ
        
        
          ćÜćî×ĂÜđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          ÖǰéĆ
        
        
          ÜîĆĚ
        
        
          îĂćÝÿøč
        
        
          ðĕéš
        
        
          üŠ
        
        
          ćăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          îìĆĚ
        
        
          Ü 3 ßîĉ
        
        
          éöĊ
        
        
          ñúìĊę
        
        
          ĒêÖêŠ
        
        
          ćÜÖĆ
        
        
          îêŠ
        
        
          ĂđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          Ö
        
        
          ÙĞ
        
        
          ćÿĞ
        
        
          ćÙĆ
        
        
          â
        
        
          ǰăĉ
        
        
          üĒöîïĊ
        
        
          êć-éĊ
        
        
          đôîàĉ
        
        
          î-1, -2 Ēúąǰ-3 đàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          ÖǰÖćøÿøš
        
        
          ćÜđàúúŤ
        
        
          ÿúć÷ÖøąéĎ
        
        
          Ö
        
        
          Abstract
        
        
          This study was
        
        
          JOǰWJUSP
        
        
          study about effects of hBD-1, -2 and -3 on osteoclastogenesis Whole-blood
        
        
          samples were obtained from healthy volunteer; human osteoclast progenitor cells were isolated from
        
        
          human peripheral blood mononuclear cells To determine the cytotoxicity of hBDs, cultured osteoclasts
        
        
          were treated with different concentrations of hBD-1, -2 or -3 by MTT assay The cells were cultured in the
        
        
          presence of non-toxic doses of hBDs during an
        
        
          JOǰWJUSP
        
        
          induction of osteoclastogenesis The results shown
        
        
          that hBD-1 could enhance multinuclear formation and formation of resorption pits On the other hand,
        
        
          hBD-3 could inhibit osteoclast formation and diminish the formation of resorption pits Whereas, hBD-2 has
        
        
          no effect on osteoclastogenesis In conclusion, the results of the present study showed a differential effect
        
        
          of hBD-1, -2 and -3 on osteoclastogenesis.
        
        
          Keywords
        
        
          Human Beta-Defensin-1, -2 and -3, Osteoclast, Osteoclastogenesis
        
        
          1
        
        
          îĆ
        
        
          Öýċ
        
        
          Öþćðøĉ
        
        
          ââćēì ÿć×ćðøĉ
        
        
          ìĆ
        
        
          îêüĉ
        
        
          ì÷ć ÙèąìĆ
        
        
          îêĒóì÷ýćÿêøŤ
        
        
          öĀćüĉ
        
        
          ì÷ćúĆ
        
        
          ÷đßĊ
        
        
          ÷ÜĔĀöŠ
        
        
          50200
        
        
          2
        
        
          Ă.ìóâ.éø. õćÙüĉ
        
        
          ßćìĆ
        
        
          îêÖøøöïĎ
        
        
          øèąĒúąðøĉ
        
        
          ìĆ
        
        
          îêüĉ
        
        
          ì÷ć ÙèąìĆ
        
        
          îêĒóì÷ýćÿêøŤ
        
        
          öĀćüĉ
        
        
          ì÷ćúĆ
        
        
          ÷đßĊ
        
        
          ÷ÜĔĀöŠ
        
        
          50200
        
        
          3
        
        
          ñý.ìóâ.éø. õćÙüĉ
        
        
          ßćìĆ
        
        
          îêÖøøöïĎ
        
        
          øèąĒúąðøĉ
        
        
          ìĆ
        
        
          îêüĉ
        
        
          ì÷ć ÙèąìĆ
        
        
          îêĒóì÷ýćÿêøŤ
        
        
          öĀćüĉ
        
        
          ì÷ćúĆ
        
        
          ÷đßĊ
        
        
          ÷ÜĔĀöŠ
        
        
          50200
        
        
          4
        
        
          Ă.ìó.éø. õćÙüĉ
        
        
          ßćýĆ
        
        
          ú÷ýćÿêøŤ
        
        
          ߊ
        
        
          ĂÜðćÖĒúąĒöĘ
        
        
          Öàĉ
        
        
          úēúđôđßĊ
        
        
          ÷ú ÙèąìĆ
        
        
          îêĒóì÷ýćÿêøŤ
        
        
          öĀćüĉ
        
        
          ì÷ćúĆ
        
        
          ÷ßĊ
        
        
          ÷ÜĔĀöŠ
        
        
          50200
        
        
          5
        
        
          ý.ìó.éø. õćÙüĉ
        
        
          ßćßĊ
        
        
          üüĉ
        
        
          ì÷ćߊ
        
        
          ĂÜðćÖĒúąüĉ
        
        
          ì÷ćÖćøüĉ
        
        
          îĉ
        
        
          ÝÞĆ
        
        
          ÷ēøÙ ÙèąìĆ
        
        
          îêĒóì÷ýćÿêøŤ
        
        
          öĀćüĉ
        
        
          ì÷ćúĆ
        
        
          ÷đßĊ
        
        
          ÷ÜĔĀöŠ
        
        
          50200
        
        
          *
        
        
          Corresponding author Tel. 087-2144854. E-mail address